Literature DB >> 28652449

Combined Use of Mammography and FNA Eliminates Pitfalls in the Management of Metaplastic Breast Carcinoma.

Diamantis I Tsilimigras1, Ioannis Ntanasis-Stathopoulos2, Dimitrios Schizas3, Anargyros Bakopoulos4, Demetrios Moris5, Gabriela-Monica Stanc6, Anastasios Tentolouris7, Soumphi Nassar8, Charitini Salla9.   

Abstract

BACKGROUND: Due to its heterogeneity, metaplastic breast carcinoma (MBC) poses diagnostic dilemmas, leading to delayed treatment, thereby aggravating the prognosis. Over the years, there has been controversy regarding the role of fine-needle aspiration (FNA) cytology in timely diagnosis. CASE REPORT: A 54-year-old woman presented with a palpable mass in the upper outer quadrant of her right breast with corresponding mammographic findings and FNA was performed. The smears revealed small- and medium-sized cohesive clusters of malignant cells with atypical nuclei. Sporadically, there was a pleomorphic population of notably large mononuclear cells, with disturbance of nuclear/cytoplasmic ratio, and binucleated or multinucleated malignant cells. The presence of chondromyxoid substance with focally embedded cells in a magenta-colored substrate was predominant in the background. These features, along with the corresponding mammographic findings, allowed for high preoperative suspicion of MBC. Surgical resection followed immediately without neoadjuvant chemotherapy; the pathology report led to the definite diagnosis of MBC. DISCUSSION: MBC is a rare clinical entity with unfavorable prognosis, thus early diagnosis is imperative regarding its management. The effectiveness of FNA in the diagnostic algorithm has been questioned, with data from literature being rather contradictory. FNA seems to provide valuable information, which should always be interpreted in correlation with the clinical and mammographic findings.
CONCLUSION: High preoperative suspicion of MBC with the combination of mammography and FNA cytology necessitated the surgical excision of the lesion as the principal treatment approach. Although the role of FNA in the diagnosis of MBC is debatable, its combination with clinical presentation and corresponding mammographic findings may prevent the administration of neoadjuvant chemotherapy in patients with ambiguous indications, given the poor response rate of this cancer subtype. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; case report; fine-needle aspiration cytology; metaplastic carcinoma

Mesh:

Year:  2017        PMID: 28652449      PMCID: PMC5566932          DOI: 10.21873/invivo.11123

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  18 in total

Review 1.  Management and Outcomes in Metaplastic Breast Cancer.

Authors:  Ioannis-Georgios Tzanninis; Elias A Kotteas; Ioannis Ntanasis-Stathopoulos; Panagiota Kontogianni; George Fotopoulos
Journal:  Clin Breast Cancer       Date:  2016-06-15       Impact factor: 3.225

2.  Matrix-producing carcinoma of the breast: fine needle aspiration cytology findings of a rare subtype of metaplastic carcinoma.

Authors:  P K Bagga; A Mittal; N C Mahajan
Journal:  Cytopathology       Date:  2011-01-17       Impact factor: 2.073

3.  Fine-needle aspiration biopsy of metaplastic carcinoma of the breast: report of a case with abundant myxoid ground substance.

Authors:  E Castellà; M C Gómez-Plaza; A Urban; M Llatjós
Journal:  Diagn Cytopathol       Date:  1996-06       Impact factor: 1.582

4.  Metaplastic carcinoma of the breast: fine-needle aspiration cytology of seven cases.

Authors:  M W Stanley; E M Tani; L Skoog
Journal:  Diagn Cytopathol       Date:  1989       Impact factor: 1.582

5.  Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07).

Authors:  Jeong Il Yu; Doo Ho Choi; Seung Jae Huh; Sung Ja Ahn; Ji Shin Lee; Kyung Hwan Shin; Youngmee Kwon; Yong Bae Kim; Chang-Ok Suh; Jin Hee Kim; Jihyoung Cho; In Ah Kim; Jong Hoon Lee; Won Park
Journal:  Clin Breast Cancer       Date:  2014-10-12       Impact factor: 3.225

Review 6.  Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature.

Authors:  Alberto Luini; Marisel Aguilar; Giovanna Gatti; Roberta Fasani; Edoardo Botteri; Jack Antonio Diaz Brito; Patrick Maisonneuve; Anna Rita Vento; Giuseppe Viale
Journal:  Breast Cancer Res Treat       Date:  2006-09-29       Impact factor: 4.872

7.  Metaplastic breast carcinoma with chondrosarcomatous differentiation: fine-needle aspiration cytology findings. A case report.

Authors:  Taku Kato; Noriyuki Tohnosu; Tomoko Suwa; Hisao Takahashi; Miyuki Tokuizumi; Toshitaka Uehara; Tadao K Kobayashi
Journal:  Diagn Cytopathol       Date:  2006-11       Impact factor: 1.582

8.  Metaplastic carcinomas of the breast--fine needle aspiration (FNA) cytology findings.

Authors:  M Nogueira; S André; E Mendonça
Journal:  Cytopathology       Date:  1998-10       Impact factor: 2.073

9.  Metaplastic carcinoma of the breast with chondroid differentiation (matrix-producing carcinoma): study of the diagnostic cost-effectiveness of fine-needle aspiration biopsy and needle core biopsy.

Authors:  M T Soler Monsó; I Català; M Terricabras; A Petit; F Climent; L Pérez-Casanovas; A Gumà; I Morilla
Journal:  Acta Cytol       Date:  2013-11-15       Impact factor: 2.319

10.  The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.

Authors:  Hung-Wen Lai; Ling-Ming Tseng; Tsai-Wang Chang; Yao-Lung Kuo; Chia-Ming Hsieh; Shou-Tung Chen; Sou-Jen Kuo; Chin-Cheng Su; Dar-Ren Chen
Journal:  Breast       Date:  2013-06-17       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.